Skip to main content
. Author manuscript; available in PMC: 2016 Apr 6.
Published in final edited form as: Nature. 2015 Dec 3;528(7580):S109–S116. doi: 10.1038/nature16041

Table 1.

Characteristics of diagnostic tests that have been approved by the World Health Organization.

Test name Detected Sensitivity Specificity 95% limit of detection Time to result Principal logistic challenge Cost
RealStar Filovirus3,13* Ebola-specific RNA NR NR 1,390 RNA cps ml−1 (95% CI = 690–5,320) Hours Kit is shipped on dry ice and should arrive frozen and be kept at −20 °C; needs equipment, including an appropriate PCR machine; needs special training; and needs high safety level in the laboratory NR
ReEBOV Antigen Rapid Test1416* Ebola virus (EBOV) VP40 antigen 91.8% (95% CI = 84.5–96.8) compared with RealStar15 84.6% (95% CI = 78.8–89.4) compared to RealStar15 6.25E+02 ng ml−1 Ebola rVP40 antigen 15 minutes Requires refrigeration at 2–8 °C, requires visual interpretation, should be used in biosafety level 4 facility or with full PPE and can use whole blood from finger prick or venipuncture NR
Xpert26,27* Ebola-specific RNA For Ebola Mayinga RNA: 100%, (95% CI = 92.9–100.0) (PPA) For Ebola Mayinga RNA: 100.0%, (95% CI = 92.9–100.0) (NPA) 232.4 RNA cps ml−1 (95% CI = 163.1– 301.6) 90 minutes Requires refrigeration at 2–8 °C, optimally should be used in a class II safety cabinet or similar, needs special training, automated process and requires a minimum of 100 μl whole blood by venipuncture US$19.80 per cartridge
LifeRiver4,28 Ebola-specific RNA 1 log10 lower limit of detection than RealStar NR 23.9 RNA cps per reaction (95% CI = 13.4–405.9) Results in 2 hours, total processing 4–6 hours Reagents must be kept at −20 °C; needs equipment, including an appropriate PCR machine; needs special training; needs high safety level in the laboratory NR
*

Test is also US Food and Drug Administration (FDA) authorized. All sensitivity, specificity and limits of detection are reported for Zaire EBOV unless otherwise stated.

Cps, copies; NPA, negative per cent agreement; NR, not reported; PCR, polymerase chain reaction; PPA, positive per cent agreement; PPE, personal protective equipment.